Literature DB >> 18310499

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.

Frederick D Goldman1, Geraldine Aubert, Al J Klingelhutz, Mark Hills, Sarah R Cooper, Wendy S Hamilton, Annette J Schlueter, Karen Lambie, Connie J Eaves, Peter M Lansdorp.   

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow (BM) failure syndrome associated with mutations in telomerase genes and the acquisition of shortened telomeres in blood cells. To investigate the basis of the compromised hematopoiesis seen in DC, we analyzed cells from granulocyte colony-stimulating factor mobilized peripheral blood (mPB) collections from 5 members of a family with autosomal dominant DC with a hTERC mutation. Premobilization BM samples were hypocellular, and percentages of CD34(+) cells in marrow and mPB collections were significantly below values for age-matched controls in 4 DC subjects. Directly clonogenic cells, although present at normal frequencies within the CD34(+) subset, were therefore absolutely decreased. In contrast, even the frequency of long-term culture-initiating cells within the CD34(+) DC mPB cells was decreased, and the telomere lengths of these cells were also markedly reduced. Nevertheless, the different lineages of mature cells were produced in normal numbers in vitro. These results suggest that marrow failure in DC is caused by a reduction in the ability of hematopoietic stem cells to sustain their numbers due to telomere impairment rather than a qualitative defect in their commitment to specific lineages or in the ability of their lineage-restricted progeny to execute normal differentiation programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310499      PMCID: PMC2343591          DOI: 10.1182/blood-2007-10-120204

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.

Authors:  N Rufer; T H Brümmendorf; B Chapuis; C Helg; P M Lansdorp; E Roosnek
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 2.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

3.  Stem cell collection and gene transfer in Fanconi anemia.

Authors:  Patrick F Kelly; Susan Radtke; Christof von Kalle; Brenden Balcik; Kimberley Bohn; Robin Mueller; Todd Schuesler; Moira Haren; Lilith Reeves; Jose A Cancelas; Thomas Leemhuis; Richard Harris; Arleen D Auerbach; Franklin O Smith; Stella M Davies; David A Williams
Journal:  Mol Ther       Date:  2007-01       Impact factor: 11.454

4.  Telomere length in leukocyte subpopulations of patients with aplastic anemia.

Authors:  T H Brümmendorf; J P Maciejewski; J Mak; N S Young; P M Lansdorp
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

5.  Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Kathleen Collins
Journal:  Genes Dev       Date:  2006-10-02       Impact factor: 11.361

6.  Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment.

Authors:  Y Dror; M H Freedman
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

7.  Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.

Authors:  Zhenyu Ju; Hong Jiang; Maike Jaworski; Chozhavendan Rathinam; Anne Gompf; Christoph Klein; Andreas Trumpp; K Lenhard Rudolph
Journal:  Nat Med       Date:  2007-05-07       Impact factor: 53.440

8.  Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

Authors:  Blanche P Alter; Gabriela M Baerlocher; Sharon A Savage; Stephen J Chanock; Babette B Weksler; Judith P Willner; June A Peters; Neelam Giri; Peter M Lansdorp
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

9.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

10.  Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.

Authors:  Amanda J Walne; Tom Vulliamy; Anna Marrone; Richard Beswick; Michael Kirwan; Yuka Masunari; Fat-Hia Al-Qurashi; Mahmoud Aljurf; Inderjeet Dokal
Journal:  Hum Mol Genet       Date:  2007-05-16       Impact factor: 6.150

View more
  26 in total

1.  Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes.

Authors:  Ken Matsui; Neelam Giri; Blanche P Alter; Ligia A Pinto
Journal:  Br J Haematol       Date:  2013-07-25       Impact factor: 6.998

Review 2.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 3.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

Review 4.  Telomere length measurement-caveats and a critical assessment of the available technologies and tools.

Authors:  Geraldine Aubert; Mark Hills; Peter M Lansdorp
Journal:  Mutat Res       Date:  2011-06-12       Impact factor: 2.433

5.  Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.

Authors:  Erin M Buckingham; Frederick D Goldman; Aloysius J Klingelhutz
Journal:  Aging Dis       Date:  2012-10-12       Impact factor: 6.745

Review 6.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07

Review 7.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

Review 8.  The telomere syndromes.

Authors:  Mary Armanios; Elizabeth H Blackburn
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

9.  Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes.

Authors:  Marie Meznikova; Natalie Erdmann; Rich Allsopp; Lea A Harrington
Journal:  Dis Model Mech       Date:  2009-10-19       Impact factor: 5.758

10.  Cell proliferation in the presence of telomerase.

Authors:  Krastan B Blagoev
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.